Dr. Robert Jarvik can't prescribe a drug, not even Lipitor. He's not licensed, remember? And now we learn that, even though he looks good in those ads rowing across a beautiful lake,it wasn't really him in that boat. The ad agency used a stand-in, or sit-in, to be precise.
The revelations are generating interest in Congress, which is investigating pharma's use of celebrity spokespeople. And the stories about Jarvik are making front-page news - after all, Lipitor is still the world's best-selling prescription med and those Jarvik ads are ubiquitous.
Pfizer is worried about squeezing as much as it can out of Lipitor, of course, because its pipeline is nearly dry and the cholesterol med loses patent protection in a couple of years. So it's not surprising that splashy ad campaigns are front and center. But he's reportedly getting paid $1.35 million, enough to take rowing lessons. Pfizer, however, could invest that in research.
At this point, you have to wonder whether Jarvik is hurting the brand. What do you think?
Should Pfizer Get Rid of Dr. Jarvik?
- Yes (69%, 218 Votes)
- No (31%, 98 Votes)
Total Voters: 316